NCT01740986

Safety and Efficacy of SA09012 in Asthma

Double Blinded, Randomized, Placebo Controlled, Multi-center, Phase II Exploratory Clinical Study to Evaluate the Efficacy, Dose-response and Safety of SA09012 in Bronchial Asthma Patients

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 225 (actual)
• Sponsor: SamA Pharmaceutical Co., Ltd · Industry
• Sex: All
• Age: 20 Years – 79 Years
• Healthy volunteers: Not accepted

Summary

Clinical Study to Evaluate the Efficacy, Dose-response and Safety of SA09012 in Bronchial Asthma Patients

Conditions

• Mild to Moderate Bronchial Asthma

Interventions

Type	Name	Description
DRUG	SA09012 Low dose	Tablet, b.i.d
DRUG	SA09012 High dose	Tablet, b.i.d
DRUG	Placebo	Tablet, b.i.d

Timeline

• Start date: 2012-11-01
• Primary completion: 2015-07-01
• Completion: 2015-11-01
• First posted: 2012-12-04
• Last updated: 2015-11-16

Locations

14 sites across 1 country: South Korea